000 | 03987nam a22006017a 4500 | ||
---|---|---|---|
008 | 201229s20202020 xxu||||| |||| 00| 0 eng d | ||
022 | _a1878-0938 | ||
024 | _a10.1016/j.carrev.2020.07.023 [doi] | ||
024 | _aS1553-8389(20)30449-8 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a33097462 | ||
245 | _aNatural History of Adapted Leaman Score Assessing Coronary Artery Disease Progression by Computed Tomography Angiography: A 7-Year Follow-Up Report. | ||
251 | _aCardiovascular Revascularization Medicine. 27:38-44, 2021 06. | ||
252 | _aCardiovasc Revasc Med. 27:38-44, 2021 06. | ||
252 | _zCardiovasc Revasc Med. 2020 Jul 26 | ||
253 | _aCardiovascular revascularization medicine : including molecular interventions | ||
260 | _c2021 | ||
260 | _fFY2021 | ||
265 | _saheadofprint | ||
265 | _sppublish | ||
266 | _d2020-12-29 | ||
268 | _aCardiovascular Revascularization Medicine. 2020 Jul 26 | ||
269 | _fFY2021 | ||
501 | _aAvailable in print through MWHC library: 2002 - present | ||
520 | _aBACKGROUND: Coronary computed tomographic angiography (CCTA) provides a non-invasive assessment of the coronary artery tree. Computed Tomography - adapted Leaman Score (CT-LeSc) has been shown to be an independent predictor of cardiac events in coronary artery disease (CAD) patients with a score greater than 5 (high). | ||
520 | _aCONCLUSION: In patients at high-risk for cardiac events, as determined by CT-LeSc, there was an increase in CT-LeSc, obstructive lesions, and calcified plaques over the 7-year follow-up period. Most of the new lesions were obstructive and non-calcified. This is the first report showing long term serial imaging CCTA changes in a high-risk population. Copyright (c) 2020 Elsevier Inc. All rights reserved. | ||
520 | _aMETHODS: Patients with multivessel CAD and CCTA assessments at baseline and follow-up were included. The CT-LeSc analysis was performed in a paired fashion. The patient-level scores and the differences between each phase were assessed by 2 analysts in an independent CoreLab. | ||
520 | _aPURPOSE: To investigate the relationship between CT-LeSc and the progression of CAD and to provide vessel- and segment-level CAD qualification and quantification at baseline and 7-year follow-up. | ||
520 | _aRESULTS: This study analyzed 248 coronary segments from 17 patients with a mean follow-up interval of 7.5 +/- 0.6 years. The mean CT-LeSc at baseline and follow-up were 14.6 +/- 4.2 and 16.9 +/- 1.5, respectively, with an absolute increase of 2.3 +/- 1.8. The mean cumulative increase of new lesions was 0.2 +/- 0.2 per year. Over time, 14.6% of the non-obstructive lesions became obstructive, and 15.0% of the non-calcified plaques became calcified. There were 29 new lesions found at follow-up, and out of these, 16 were obstructive and 19 were non-calcified. | ||
546 | _aEnglish | ||
650 | _a*Coronary Artery Disease | ||
650 | _a*Coronary Stenosis | ||
650 | _a*Plaque, Atherosclerotic | ||
650 | _aComputed Tomography Angiography | ||
650 | _aCoronary Angiography | ||
650 | _aCoronary Artery Disease/dg [Diagnostic Imaging] | ||
650 | _aFollow-Up Studies | ||
650 | _aHumans | ||
650 | _aPredictive Value of Tests | ||
650 | _aRisk Assessment | ||
650 | _aTomography, X-Ray Computed | ||
651 | _aMedStar Heart & Vascular Institute | ||
651 | _aMedStar Washington Hospital Center | ||
657 | _aJournal Article | ||
700 | _aDan, Kazuhiro | ||
700 | _aGarcia-Garcia, Hector M | ||
700 | _aHideo-Kajita, Alexandre | ||
700 | _aOzaki, Yuichi | ||
700 | _aWopperer, Samuel | ||
790 | _aBittencourt M, Cavalcante R, Dan K, Falcao BAA, Falcao JLA, Freire AFD, Garcia-Garcia HM, Hideo-Kajita A, Lemos PA, Ozaki Y, Pinheiro TL, Ribeiro E, Rochitte CE, Rubarth R, Soares P, Wopperer S | ||
856 |
_uhttps://dx.doi.org/10.1016/j.carrev.2020.07.023 _zhttps://dx.doi.org/10.1016/j.carrev.2020.07.023 |
||
942 |
_cART _dArticle |
||
999 |
_c5867 _d5867 |